| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.27 | 0.09 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |